CA125 validated as important biomarker in prediagnostic specimens – HemOncToday
April 29, 2009
|
ca125's integrity as a biomarker of ovarian cancer was upheld with the results of a phase-3 validation study of ovarian cancer biomarkers in prediagnostic specimens taken from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. … |
Less frequent screening possible in men with low PSA – HemOncToday
April 29, 2009
|
Less frequent screening possible in men with low PSA
HemOncToday, NJ New data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial indicate that less than 1% of men with a low initial PSA value increased to a PSA >4 ng/mL — the PSA trigger value for biopsy — within five years. … |
ImmunoCellular Therapeutics Granted Monoclonal Antibody Technology … – Earthtimes (press release)
April 29, 2009
|
ImmunoCellular Therapeutics Granted Monoclonal Antibody Technology …
Earthtimes (press release), UK 7498129 entitled “Myeloma Cell and Ovarian Cancer Cell Surface Glycoproteins, Antibodies Thereto, and Uses Thereof,” covers the use of IMUC's antibodies to measure the effectiveness of the company's proposed treatment of multiple myeloma and ovarian … |
Weekly Chemotherapy for Recurrent Ovarian and Uterine Cancers – Medscape
April 29, 2009
|
Topotecan and docetaxel are commonly used in recurrent ovarian cancer, and there is evidence of "an incomplete cross-resistance between these 2 agents," the authors note. Because the antitumor activity of topotecan and docetaxel might not be … |
Berek on health risks of removing ovaries – Stanford University News
April 28, 2009
|
Berek on health risks of removing ovaries
Stanford University News, CA Although it also led to a decreased risk of breast and ovarian cancer, ovary removal failed to provide an overall survival benefit. Jonathan Berek, MD, professor and chair of obstetrics and gynecology, was a co-author of the paper. … |
1st Annual Hope Hike 2009 Being Organized to Raise Awareness … – Today’s THV
April 28, 2009
|
Hope Hike, the Arkansas Ovarian Cancer Coalition and Partners for Pinnacle, Inc. announces Hope Hike 2009: The Lisette C. Johnson Memorial Hike for Ovarian Cancer Education and Research to take place at Pinnacle Mountain State Park on Saturday, May 9, … |
Alimta® Active Against Platinum-resistant Ovarian Cancer – Cancer Consultants
April 28, 2009
|
Alimta® Active Against Platinum-resistant Ovarian Cancer
Cancer Consultants, ID According to the results of a Phase II clinical trial, treatment with the chemotherapy drug Alimta® (pemetrexed) reduced the extent of cancer in some women with recurrent, platinum-resistant ovarian cancer. These results were published in the Journal … |
Women Who Keep Ovaries Live Longer – New York Times
April 27, 2009
 Haber 27 |
Women Who Keep Ovaries Live Longer
New York Times, United States By RONI CARYN RABIN Each year, hundreds of thousands of women who undergo hysterectomies have their ovaries removed along with their uterus, a practice meant to protect them from ovarian cancer. But a new study has found that women who keep their … Removing ovaries increases overall death risk Ovaries not to be removed in hysterectomy? |
Zeltia says Irvalec efficient for lung cancer – Reuters
April 27, 2009
|
Yondelis is already sold in most of Europe to treat soft tissue sarcoma and is awaiting approval for the treatment of ovarian cancer in Europe and in the United States with partner Johnson & Johnson (JNJ.N). (Reporting by Tracy Rucinski) |
Cancer walk slated for May in Des Moines – DesMoinesRegister.com
April 27, 2009
|
Cancer walk slated for May in Des Moines
DesMoinesRegister.com, IA A walk to raise funds and generate awareness for ovarian cancer will be held next month. The second annual “Break the Silence Walk” will begin at 9 am May 9 at Gray's Lake in Des Moines. All proceeds will go toward education and awareness of ovarian … |